deanol has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audebert, C; Blin, O; Casse-Perrot, C; Chopin, P; Kaladjian, A; Marien, M; Micallef, J; Pitel, S; Sokoloff, P; Tisne-Versailles, J; Zaim, M | 1 |
| Dimpfel, W; Hofmann, HC; Prohaska, A; Schellenberg, R; Schober, F | 1 |
2 trial(s) available for deanol and Cognition Disorders
| Article | Year |
|---|---|
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
Topics: Adult; Animals; Avoidance Learning; Cognition Disorders; Cross-Over Studies; Deanol; Double-Blind Method; Glutamates; Humans; Male; Memory Disorders; Microdialysis; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Young Adult | 2009 |
Source density analysis of functional topographical EEG: monitoring of cognitive drug action.
Topics: Adult; Aged; Brain; Cognition Disorders; Deanol; Double-Blind Method; Drug Combinations; Drug Monitoring; Electroencephalography; Female; Humans; Male; Middle Aged; Minerals; Placebos; Vitamins | 1996 |